» BiPar Sciences Expands Phase 2 <b>Clinical Trials</b> of BSI-201, a Novel <b>...</b>
Memorial Sloan-Kettering Cancer Center Investigators to Assess BSI-201 Therapy in BRCA-Negative Ovarian Cancer Patients - BRISBANE, Calif., May 8 /- BiPar Sciences, Inc. today announced the expansion…